Form 4 Tracker
Hannah Valantine

Director · 6 filings · Latest: Jul 16, 2026

BridgeBio Pharma, Inc.
CareDx, Inc.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
CDNA
Hannah ValantineDirectorJul 16, 2026
Sale
$36.1528,779$1.0M36,686
CDNA
Hannah ValantineDirectorJul 16, 2026
Option Exercise
$14.7628,779$424.9K65,465
CDNA
HANNAH VALANTINEJul 16, 2026
Proposed Sale
$29.7528,779$856.2K
BBIO
Hannah ValantineDirectorJun 23, 2026
Sale
$68.572,196$150.6K9,259
BBIO
Hannah ValantineDirectorJun 22, 2026
Sale
$68.002,808$190.9K11,455
BBIO
Hannah ValantineDirectorJun 22, 2026
Option Exercise
$41.732,808$117.2K14,263
BBIO
HANNAH A VALANTINEJun 23, 2026
Proposed Sale
$68.572,196$150.6K
BBIO
HANNAH A VALANTINEJun 22, 2026
Proposed Sale
$68.002,808$190.9K
CDNA
Hannah ValantineDirectorJun 15, 2026
Sale
$23.1112,103$279.7K36,686
CDNA
HANNAH VALANTINEJun 15, 2026
Proposed Sale
$22.9712,103$278.0K
BBIO
Hannah ValantineDirectorMar 10, 2026
Sale
$72.008,671$624.3K7,465
BBIO
Hannah ValantineDirectorMar 10, 2026
Option Exercise
$27.368,671$237.2K16,136
BBIO
HANNAH A VALANTINEMar 10, 2026
Proposed Sale
$72.008,671$624.3K
BBIO
Hannah ValantineDirectorFeb 27, 2026
Sale
$67.4125,484$1.7M7,465
BBIO
Hannah ValantineDirectorFeb 27, 2026
Option Exercise
$48.4525,484$1.2M32,949
BBIO
HANNAH A VALANTINEFeb 27, 2026
Proposed Sale
$67.4125,484$1.7M
BBIO
Hannah A ValantineNov 12, 2025
Proposed Sale
$66.0725,484$1.7M
BBIO
DENIS VON KAEPPLER IRA ROLLOVERJun 26, 2025
Proposed Sale
$44.031,891$83.3K
BBIO
HANNAH VALANTINE & DENIS VON KAEPPLERJun 26, 2025
Proposed Sale
$44.011,542$67.9K
BBIO
HANNAH A VALANTINE & DENIS VON KAEPPLER JT TENJun 26, 2025
Proposed Sale
$44.11876$38.6K

Page 1 of 2

Next →